A new regimen for the first line anti-retroviral therapy (ART) treatment, known as TLE400 brings relief to people living with HIV as it harbours less side-effects as compared to previous regimes. SOURCE: The SundayMail Zimbabwe has been using TLE600 (which contains 600mg Efavirenz) which has serious side-effects which include dizziness, insomnia, unusual dreams, blurred vision,